hybrid everted esophagogastric anastomosis
OtherOther names: no other names
NCT Number: NCT01139229
The investigators improved the hybrid everted esophagogastrostomy and expected to prevent the incidence of anastomotic stricture. The purpose of this study is to determine the clinical value of this kind of operation type, and analyzes the clinicopathological factors causing the postoperative complications.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
This randomized clinical trial compared a hybrid everted esophagogastric anastomosis with conventional hand-sewn or stapled esophagogastrostomy for prevention of anastomotic stricture. The patients were completely randomized to receive either a hybrid everted esophagogastric anastomosis (HE group), or the conventional hand-sewn (HS group), or a stapled (SA group) anastomosis, after the removal of esophageal tumor. The primary outcome measured the incidence of anastomotic stricture at 3 months after the operation (defined as the diameter of the anastomotic orifice <= 0.8 cm on esophagogram), analyzed by intention-to-treat.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: no other names
Other names: no other names
Other names: no other names
Time frame: three months
the anastomotic stricture is defined as the diameter of the anastomotic orifice <= 0.8 cm on esophagogram
Time frame: three months
0:No dysphagia on solid diet
Time frame: three months
0:no reflux on semi-supine position
Time frame: three months
Sichuan University
Other
Phase III Study of Hybrid-everted Versus Hand-sewn of Stapled Esophagogastrostomy in Prevention of Anastomotic Stricture
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01719926
Adnexal Diseases, Colonic Diseases
Amsterdam, Netherlands
View Trial DetailsNCT00213486
Digestive System Diseases, Digestive System Neoplasms
Rouen, France
View Trial DetailsNCT02359968
Digestive System Diseases, Digestive System Neoplasms
Angers, France
View Trial DetailsNCT06027515
Digestive System Diseases, Digestive System Neoplasms
Boston, Massachusetts, United States
View Trial Details